EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant Klebsiella pneumoniae with synergistic ceftriaxone combination

Sayed E El-Sayed, Khaled M Aboshanab, Hesham Ali El Enshasy, Mohamed H Al-Agamy, Khalid Alyahya, Ann A Elshamy

Frontiers in Cellular and Infection Microbiology · 16.07.2026 · 16

DOI: 10.3389/fcimb.2026.1867536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 16.07.2026. Verfasst von Sayed E El-Sayed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Sixth of October City, Giza, Egypt. Hauptthemen laut MEDLINE: Biofilms, Klebsiella pneumoniae, Ceftriaxone, Anti-Bacterial Agents. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Global public health is seriously threatened by the rising incidence of multidrug-resistant (MDR) Klebsiella pneumoniae , underscoring the critical need for innovative antimicrobial approaches. Herein, the antibacterial and antibiofilm activities of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate (ODHP) and its nanosponge formulation (ODHP-NS) were evaluated against clinical MDR K. pneumoniae isolates, and the potential synergistic interaction between ODHP-NS and ceftriaxone was investigated using the checkerboard assay and further confirmed by time–kill kinetics. Results showed that ODHP-NS exhibited enhanced antibacterial activity compared to ODHP, with lower MIC 50 and MIC 90 values (32 vs. 96 µg/mL and 128 vs. 256 µg/mL, respectively), indicating improved efficacy following nanosponge formulation. Both ODHP and ODHP-NS demonstrated significant inhibition of biofilm formation at sub-inhibitory concentrations (1/2 and 1/4 MIC), with ODHP-NS showing significantly higher antibiofilm activity ( p < 0.0001). Fractional inhibitory concentration index (FICI) values indicated synergistic to additive effects in most tested combinations, and the time–kill kinetics demonstrated a pronounced bactericidal effect, achieving a ≥3 log 10 reduction in bacterial counts compared to the most active single agent, with no evidence of bacterial regrowth over 24 h. It was concluded that nanosponge formulation significantly enhanced the antibacterial and antibiofilm properties of ODHP and effectively potentiated the activity of ceftriaxone against MDR K. pneumoniae . This study highlights ODHP-NS as a potential antimicrobial adjuvant for combating MDR K. pneumoniae infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsKlebsiella pneumoniaeCeftriaxoneAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialPropionatesDrug SynergismMicrobial Sensitivity TestsHumansThird Generation CephalosporinsSecond Generation CephalosporinsMicrobial Viability

Stichwörter der Autor:innen

Klebsiella pneumoniaeODHPantibiofilm activityantimicrobial synergyceftriaxonemultidrug resistancenanosponge

Substanzen

CeftriaxoneAnti-Bacterial AgentsPropionatesThird Generation CephalosporinsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Sixth of October City, Giza, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
  • Innovation Centre in Agritechnology for Advanced Bioprocessing (ICA), Universiti Teknologi Malaysia (UTM), Pagoh, Johor, Malaysia.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Förderung

  • King Saud University

Zitieren

APA

El-Sayed, S. E., Aboshanab, K. M., El Enshasy, H. A., Al-Agamy, M. H., Alyahya, K., & Elshamy, A. A. (2026). Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant Klebsiella pneumoniae with synergistic ceftriaxone combination. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1867536

Vancouver

El-Sayed SE, Aboshanab KM, El Enshasy HA, Al-Agamy MH, Alyahya K, Elshamy AA. Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant Klebsiella pneumoniae with synergistic ceftriaxone combination. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1867536

BibTeX
@article{ElSayed2026,
  author = {El-Sayed, Sayed E and Aboshanab, Khaled M and El Enshasy, Hesham Ali and Al-Agamy, Mohamed H and Alyahya, Khalid and Elshamy, Ann A},
  title = {Octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate nanosponges: enhanced antibacterial and antibiofilm activity against multidrug-resistant Klebsiella pneumoniae with synergistic ceftriaxone combination},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1867536}
}
Kostenlos starten →